Aveanna Healthcare Holdings Inc. - Common Stock (AVAH)
6.8200
+0.00 (0.00%)
NASDAQ · Last Trade: May 13th, 8:28 AM EDT
Detailed Quote
Previous Close
6.820
Open
-
Bid
6.570
Ask
7.070
Day's Range
N/A - N/A
52 Week Range
3.730 - 10.32
Volume
768
Market Cap
1.27B
PE Ratio (TTM)
18.43
EPS (TTM)
0.4
Dividend & Yield
N/A (N/A)
1 Month Average Volume
1,176,216
Chart
About Aveanna Healthcare Holdings Inc. - Common Stock (AVAH)
Aveanna Healthcare Holdings is a leading provider of high-quality, integrated healthcare services aimed at improving the quality of life for patients with complex medical needs. The company specializes in delivering home health care services, pediatric therapy, and essential medical solutions to both children and adults, helping them navigate their healthcare journeys in comfortable and familiar environments. With a focus on personalized care and a commitment to addressing the unique needs of each patient, Aveanna combines innovative clinical approaches and compassionate support to enhance health outcomes and foster overall well-being within the communities it serves. Read More
ATLANTA, May 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026. Management will present at 2:40pm CST and will also host 1x1 investor meetings that same day. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call.
ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026. Management will host 1x1 investor meetings that day.
ATLANTA, April 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 14, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare (NASDAQ: AVAH) today announced the second year of Aveanna Cares, the company’s month-long, team-based volunteer initiative dedicated to giving back to the communities Aveanna serves nationwide. Building on the success of its inaugural year, Aveanna Cares returns this April with expanded participation, deeper community partnerships, and an ambitious goal of delivering 7,500 volunteer hours across the country.
ATLANTA, March 19, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period and fiscal year ended January 3, 2026.
ATLANTA, March 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Family First Holding, LLC ("Family First Homecare").
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 19, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care in the home, announced today that Aveanna Home Health and Hospice, a division of Aveanna Healthcare, has been awarded a Disease Program Certification for Heart Failure under the CHAP Disease Program Standards.
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced updated full year guidance for fiscal year 2025 (year ended January 3, 2026) and its initial full year guidance for fiscal year 2026 (year ending January 2, 2027).
ATLANTA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026.
ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the BofA Securities Home Care Conference virtually on December 9, 2025. Management will present at 12:30pm EST and will also host 1x1 investor meetings that same day. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call.
ATLANTA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended September 27, 2025.
ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today the pricing of the previously announced secondary offering by certain selling stockholders affiliated with J.H. Whitney Equity Partners VII, LLC (the “Selling Stockholders”) of 10,000,000 shares of its common stock at a public offering price of $9.00 per share (the “Offering”). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of the Company’s common stock. The Selling Stockholders will receive all of the net proceeds from the Offering. The Company is not offering any shares of its common stock in the Offering and will not receive any of the proceeds from the sale of the shares offered by the Selling Stockholders. The Offering is expected to settle on October 23, 2025, subject to customary closing conditions.
